Integer Holdings Enters Buyout Endgame With KKR on the Register

Integer Holdings arrives at this week with its story almost entirely rewritten: a private equity buyer now holds 14% of the stock, an activist Schedule 13D sits on the SEC register, and index trackers are bracing to unwind mandatory positions as the KKR deal moves toward close.

Among its closest medical device peers, short positioning looks moderate. MMSI and CNMD each rose more than 3% over the past week, while SMTI fell nearly 6%, leaving ITGR's flat 0.1% gain in the middle of the pack. Integer itself carries 8.2% of its free float short, a meaningful level for a name in announced-deal territory, though it has eased about 2.6% over the past week after a brief spike to around 3.1 million shares on October 13. The borrow market remains entirely unconstrained: availability is running at roughly 1,524%, meaning shares to lend dwarf the short book by a factor of fifteen, and cost to borrow has retreated sharply from a mid-October high of 0.95% back to 0.49%. No squeeze pressure is visible from the lending side.

Options positioning has shifted in a way that stands out. The put/call ratio has climbed to 0.045, more than two standard deviations above its 20-day average of 0.036. For a stock whose 52-week PCR range runs all the way to 1.58, the absolute level is still low. But the directional move is notable: the ratio had been grinding near its yearly floor through late September and early October before ticking up over the past fortnight, consistent with some buyers of downside protection around an event-driven setup. The next earnings print is scheduled for October 22, though in deal context the quarterly numbers are a secondary concern.

The structural story is KKR. Tarheel Investors III, the KKR vehicle, filed a Schedule 13D on October 13 disclosing a 14% stake in Integer. That is the highest-signal event type in the activist register: a 13D filing declares active intent, not passive ownership. ORTEX's data shows the filing as the company's first 13D event. BlackRock sits at 15.7% as the largest external holder, with Invesco and the two Vanguard entities each above 5%. As always with 13D/G disclosures, stakes are event-driven around the 5% threshold and holders dropping below that level may not file again.

The index mechanics that follow a completed acquisition add a mechanical dimension to the week ahead. ORTEX forecasts an 84% probability that Integer is deleted from the Russell 2000 and Russell 3000, and 80% for the S&P SmallCap 600, with estimated announcement on October 22, a trade date of October 27, and an effective date of October 28. Across 351 similar cash-acquisition deletions from the Russell indices, the median move from announcement to effective date was minus 4.3%, with 80% of names moving in that direction. Trade-day volume ran at 9.1 times normal. For the S&P SmallCap 600, the comparable figures across 87 past changes show a median of minus 4.8% and volume at 11.1 times normal. These are descriptions of what past mechanical unwinds did, not forecasts of what this one will produce.

The Street aligned decisively against the stock after Q2 results in early August: Benchmark, Oppenheimer, Truist and Freedom Capital all cut from buy-equivalent ratings to hold, while Wells Fargo raised its target from $84 to $127 without changing its equal-weight view. The consensus mean target of $121.80 now sits slightly below the current price of $126.70, leaving virtually no return potential on a standalone basis. That arithmetic matters less once a definitive acquisition price is set, but it underscores why independent upside arguments have faded from the analyst community. The factor picture reflects the same hesitation: EV/EBIT ranks in just the 24th percentile of the universe, and the forward EPS growth score is at the 33rd. Momentum is the lone pillar with any force, a product of the 33% one-month price gain driven by deal premium rather than operational recovery.

The date to watch is October 22: the earnings release, the expected index-deletion announcement, and any update on deal timeline all converge on the same session.